Concepedia

Christopher J. Nicolai

CJ

9

Publications

672

Citations

9

H-Index

2013

Active since

Affiliations

University of California, Berkeley(Current)

TRIA Bioscience (United States)

CTI BioPharma (United States)

Metis Design Corporation (United States)

Christopher J. Nicolai is an author at University of California, Berkeley specializing in medicine, tumor immunity, and t cell immunity.

Top concepts

MedicineImmunologyCell BiologyImmune SystemImmunotherapyTumor ImmunityImmunodominanceT Cell ImmunityRadiation OncologyImmune Surveillance

Publications per year

2013–2024

9

Publications

9

NK cells mediate clearance of CD8 <sup>+</sup> T cell–resistant tumors in response to STING agonists

Christopher J. Nicolai, Natalie K. Wolf, I-Chang Chang et al. · Science Immunology · 2020 · 249 citations · Full text

Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering

Kathryn Michels, Alyssa Sheih, Susana Hernández et al. · Journal for ImmunoTherapy of Cancer · 2023 · 76 citations · Full text

Positive and Negative Regulation of the Master Metabolic Regulator mTORC1 by Two Families of Legionella pneumophila Effectors

Justin A. De Leon, Jiazhang Qiu, Christopher J. Nicolai et al. · Cell Reports · 2017 · 73 citations · Full text

Mitochondrial Function, Natural Sciences, Legionella Pneumophila Effectors +8

Tumor-induced disruption of the blood-brain barrier promotes host death

Jung Kim, Hsiu‐Chun Chuang, Natalie K. Wolf et al. · Developmental Cell · 2021 · 73 citations · Full text

Neuro-oncology, Blood–brain Barrier, Apoptosis +8

In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand

Christopher J. Nicolai, Maura H. Parker, Jim Qin et al. · Blood · 2024 · 62 citations · Full text

Rows per page

1–5 of 9